2012-10-06 19:11:55 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Nymox Pharmaceutical Corporation - Product Pipeline Review - 2012" provides data on the Nymox Pharmaceutical Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Nymox Pharmaceutical Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Nymox Pharmaceutical Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Nymox Pharmaceutical Corporation - Brief Nymox Pharmaceutical Corporation overview including business description, key information and facts, and its locations and subsidiaries.
*

Review of current pipeline of Nymox Pharmaceutical Corporation human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Nymox Pharmaceutical Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Nymox Pharmaceutical Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468499_nymox_pharmaceutical_corporation_prod ..


Reasons to buy

* Evaluate Nymox Pharmaceutical Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Nymox Pharmaceutical Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Nymox Pharmaceutical Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Nymox Pharmaceutical Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Nymox Pharmaceutical Corporation and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Nymox Pharmaceutical Corporation Snapshot
Nymox Pharmaceutical Corporation Overview
Key Information
Key Facts
Nymox Pharmaceutical Corporation - Research and Development Overview
Key Therapeutic Areas
Nymox Pharmaceutical Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Nymox Pharmaceutical Corporation - Pipeline Products Glance
Nymox Pharmaceutical Corporation - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Nymox Pharmaceutical Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Nymox Pharmaceutical Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Nymox Pharmaceutical Corporation - Drug Profiles
NX-1207
Product Description
Mechanism of Action
R&D Progress
NXB-4221
Product Description
Mechanism of Action
R&D Progress
NXB-5886
Product Description
Mechanism of Action
R&D Progress
NXD-1191
Product Description
Mechanism of Action
R&D Progress
NXD-3109
Product Description
Mechanism of Action
R&D Progress
NXD-5150
Product Description
Mechanism of Action
R&D Progress
NXD-9062
Product Description
Mechanism of Action
R&D Progress
NXT-1021
Product Description
Mechanism of Action
R&D Progress
Oncology Products
Product Description
Mechanism of Action
R&D Progress
Nymox Pharmaceutical Corporation - Pipeline Analysis
Nymox Pharmaceutical Corporation - Pipeline Products by Therapeutic Class
Nymox Pharmaceutical Corporation - Pipeline Products by Route of Administration
Nymox Pharmaceutical Corporation - Recent Pipeline Updates
Nymox Pharmaceutical Corporation - Dormant Projects
Nymox Pharmaceutical Corporation - Company Statement
Nymox Pharmaceutical Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Nymox Pharmaceutical Corporation, Recent Developments
Nymox Pharmaceutical Corporation- Press Release
Jul 31, 2012: Nymox Pharma Reports Positive Results From Combined Statistical Analysis Of Long Term Follow-Up Studies Of BPH Drug
Jul 17, 2012: Nymox Pharma Provides Update On Phase III Pivotal Trials Of NX-1207
Jul 11, 2012: Nymox Pharma Completes Enrollment In Phase III Benign Prostatic Hyperplasia Re-Injection Study Of NX-1207
Jul 09, 2012: Nymox Announces Positive Safety Monitoring Committee Results For Phase III NX02-0020 Repeat Injection Study For NX-1207
Jun 12, 2012: Nymox Pharma Enrolls First Patient In Phase II Prostate Cancer Clinical Trial
May 21, 2012: Nymox Presents New Positive Data On NX-1207 At American Urological Association Annual Meeting
May 16, 2012: Nymox To Present Data On NX-1207 At American Urological Association Annual Meeting
Apr 26, 2012: Nymox Pharma Announces Positive Safety Monitoring Committee Results For Phase III NX-1207 Trials For Benign Prostatic Hyperplasia
Apr 24, 2012: Nymox To Present Data On NX-1207 At American Urological Association Annual Meeting

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468499&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.